Association of Cannabinoid Specialists
James Winokur is an accomplished executive with extensive experience in the cannabis industry and business development. Currently serving as the Chief Executive Officer of CitraChem Corp., James leads the company in creating ultra-pure phytocannabinoid molecules. James also contributes as a member of the Board of Directors for the Association of Cannabinoid Specialists, focusing on patient care and clinical best practices in cannabinoid medicine. Previously, James founded High Power Consulting, acted as CEO of Berkshire Roots, and held leadership roles at MariMed Inc., CannaKorp, Inc., and PTC, where strategic initiatives consistently led to enhanced revenue and operational excellence. Academic credentials include an MBA in Marketing and Operations from Boston College Carroll School of Management and a BA in Political Science from Boston College.
This person is not in the org chart
This person is not in any teams
Association of Cannabinoid Specialists
The Association of Cannabis Specialists ensures the highest standards in the practice of cannabis medicine, safeguards patient care with clinical best practices, and interfaces with other stakeholders in the cannabis community. We believe that patients are uniquely vulnerable and have very different needs than recreational users. We provide evidence and experience-based education for patients, cannabis clinicians, referring clinicians, and lawmakers to help them understand cannabis medicine and make informed decisions. We are a political organization striving to implement best practices in the laws and regulations at the federal, state, and international levels. Our Core Values: • Patients are a vulnerable group who deserve the highest standard of medical care and products. • Recreational use is not the same as medical use. These groups have different goals and needs and must be addressed separately. • Prohibition of cannabis is a major public health hazard that has failed to decrease drug use and has led to unsupportable consequences. • Cannabis is medicine. It should be regulated like other medications and be available by prescription including in botanical form. • Cannabis products should not make unsubstantiated medical claims. Products should be required to meet strict standards of safety, bioavailability, and efficacy. • Dispensaries should operate like pharmacies. They should provide products that are safe and effective. They should not provide medical advice to patients. They should not contradict patients’ clinicians’ orders.